NCT06275087

Brief Summary

The goal of this clinical trial is to compare two groups of patients going in general anesthesia for intraoral surgery, the first group TIVA with propofol and the second group inhalational with sevoflurane. The main questions it aims to answer are to asses speed and quality of recovery from general anesthesia. Participants will fill out a questionnaire to evaluate the quality of recovery from anesthesia using the QoR-40 1h, 24h, and 30 days after waking up from anesthesia in comparison to the results of the same questionnaire before surgery. Also, the investigators will perform a hand grip and bite strength test on the patients after waking up from anesthesia in the operating room, after 1 hour in the recovery room, and after 24 hours compared to preoperative values. The investigators will compare TIVA and Volatile groups to see if there are any differences in recovery seed, muscle strength recovery, postoperative nausea and vomiting, and shivering between groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Apr 2024Jul 2026

First Submitted

Initial submission to the registry

February 9, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 10, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

1.6 years

First QC Date

February 9, 2024

Last Update Submit

December 17, 2025

Conditions

Keywords

TIVAPropofolIntraoral surgeryPostoperative recoveryrecovery of muscle strenght

Outcome Measures

Primary Outcomes (1)

  • "Quality of recovery from anesthesia" QoR-40 questionnaire

    The QoR-40 is a recovery-specific and patient-rated questionnaire that contains 40 items measuring five dimensions: the physical comfort (12 items), emotional state (nine items), physical independence (five items), psychological support (seven items) and pain (seven items). The total score and subscales of the QoR-40 are measured using a five-point Likert scale (for positive items: 1 = none of the time, 5 = all of the time; for negative items, the scoring was reversed) and individual scores are then added together, with the minimum score being 40 points and the maximum score being 200 points. The QoR-40 was specifically designed to measure a patient's health status after surgery and anesthesia, and its completion time generally ranges from three to 10 min. The Japanese version of the QoR-40 was also validated according to standard methods of cultural adaptation and psychometric analysis in 2011.

    1 hour, 24 hour, 30 day

Secondary Outcomes (3)

  • bite strength and hand grip strength

    after waking in OR up to 10 min, 1 hour after waking, 24 hour after waking

  • Postoperative nausea and vomiting

    24 hours

  • Postoperative shivering

    2 hour

Study Arms (2)

TIVA group

EXPERIMENTAL

The study involves patients in an operating room undergoing standard procedures. The induction procedure for anesthesia is the same for both groups, using sufentanil, propofol, and cisatracurium. In the TIVA group, anesthesia is maintained with continuous propofol infusion and intermittent cisatracurium doses, guided by neuromuscular and electroencephalogram monitoring. At the end of surgery, neuromuscular block is reversed, and extubation occurs when the train-of-four (TOF) index is over 90%. Muscle strength and bite force are measured at different intervals before and after anesthesia, using specific instruments. Additionally, patients fill out the Quality of recovery-40 (Qor-40) questionnaire at various time points to assess the quality of recovery after surgery and anesthesia.

Drug: Propofol

Volatile group

ACTIVE COMPARATOR

In the volatile group, anesthesia is maintained with inhaled sevoflurane and intermittent cisatracurium doses. Cisatracurium is repeated based on TOF ratio, and anesthesia depth is controlled by BIS, maintaining values between 25 and 50. Drug doses are adjusted according to TOF and BIS values.

Drug: Sevoflurane

Interventions

The experimental group will not receive volatile anesthetic, instead, they will receive propofol infusion

Also known as: TIVA
TIVA group

The control group will not receive TIVA, instead, they will receive sevoflurane via inhalation

Also known as: general volatile anesthesia
Volatile group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • ASA status 3 and higher,
  • The need for postoperative care in the ICU,
  • Surgery lasting more than 2 hours,
  • Surgical procedures that in the operative plan include injuries to the grip of the masticatory muscles, the masticatory muscles themselves, and procedures on the bone, and thus may result in a difference in the strength of the bite. Masticatory muscles are defined as musculus pterygoideus lateralis, musculus pterygoideus medialis, musculus temporalis and musculus masseter.
  • Surgical procedures on the bone where the bite force test alone could cause injury
  • Patients with diseases of the neuromuscular junction and muscle diseases, myopathy, dystrophy
  • Patients taking medications that can cause myopathy or muscle weakness
  • Known allergies to drugs used in the trial,
  • Refusing to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Centre Zagreb

Zagreb, 10000, Croatia

RECRUITING

Related Publications (32)

  • Diniz JA, Siqueira ADS, Araujo GM, Faro TF, Torres LHS, Oliveira E Silva ED, Laureano Filho JR. Intraoral Approach for Surgical Treatment of Psammomatoid Juvenile Ossifying Fibroma. J Craniofac Surg. 2020 May/Jun;31(3):e306-e309. doi: 10.1097/SCS.0000000000006171.

    PMID: 31934971BACKGROUND
  • Ferreira, C. C., Pereira, M. B. F., Bruzinga, F. F. B., Castro, H. H. O., Souto, G. R., Souza, P. E. A., & De Oliveira, L. J. (2022, September). AN UNUSUAL INTRAORAL LIPOMA: A CASE REPORT. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 134(3), e119. https://doi.org/10.1016/j.oooo.2022.01.212

    BACKGROUND
  • Frerich, B. (2020). Complications in Maxillofacial Tumor Surgery. Complications in Cranio-Maxillofacial and Oral Surgery, 253-277. https://doi.org/10.1007/978-3-030-40150-4_13

    BACKGROUND
  • Tamunobelema, D. M. S., & Uruaka, C. I. (2023, March 11). General Anaesthetic Agents and its Implication on the Cardiovascular System: A Systemic Review. Saudi Journal of Medical and Pharmaceutical Sciences, 9(03), 171-183. https://doi.org/10.36348/sjmps.2023.v09i03.006

    BACKGROUND
  • Qurbani, B., & Karim, S. B. (2022, December 29). Comparison among complications of common intravenous anesthetic drugs during general anesthesia for patients undergoing surgery in Sulaimani city. Annals of the College of Medicine, Mosul, 44(2), 159-165. https://doi.org/10.33899/mmed.2022.136178.1166

    BACKGROUND
  • Fiorda-Diaz, J., Stoicea, N., & Bergese, S. (2017). Anesthetic Agents. Essentials of Neuroanesthesia, 123-129. https://doi.org/10.1016/b978-0-12-805299-0.00007-5

    BACKGROUND
  • Hao X, Ou M, Zhang D, Zhao W, Yang Y, Liu J, Yang H, Zhu T, Li Y, Zhou C. The Effects of General Anesthetics on Synaptic Transmission. Curr Neuropharmacol. 2020;18(10):936-965. doi: 10.2174/1570159X18666200227125854.

    PMID: 32106800BACKGROUND
  • Monisha, B., Madhusudhana, R., & Sujatha, M. (2023). Effects of Isoflurane versus Propofol for Postoperative Neurocognitive Recovery in Patients Undergoing Surgery under General Anaesthesia: A Randomised Clinical Study. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2023/62147.17888

    BACKGROUND
  • Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019 Mar;74(3):373-379. doi: 10.1111/anae.14569. Epub 2019 Jan 15.

    PMID: 30648259BACKGROUND
  • Saha, D. S. C., & Seraji, D. S. I. (2023, April 16). A Comparative Study of Propofol and Sevoflurane for General Anesthesia in Laparoscopic Appendectomy. Scholars Journal of Applied Medical Sciences, 11(04), 753-757. https://doi.org/10.36347/sjams.2023.v11i04.014

    BACKGROUND
  • Yang L, Chen Z, Xiang D. Effects of intravenous anesthesia with sevoflurane combined with propofol on intraoperative hemodynamics, postoperative stress disorder and cognitive function in elderly patients undergoing laparoscopic surgery. Pak J Med Sci. 2022 Sep-Oct;38(7):1938-1944. doi: 10.12669/pjms.38.7.5763.

    PMID: 36246684BACKGROUND
  • Miao L, Lv X, Huang C, Li P, Sun Y, Jiang H. Long-term oncological outcomes after oral cancer surgery using propofol-based total intravenous anesthesia versus sevoflurane-based inhalation anesthesia: A retrospective cohort study. PLoS One. 2022 May 13;17(5):e0268473. doi: 10.1371/journal.pone.0268473. eCollection 2022.

    PMID: 35559987BACKGROUND
  • Zhou, Y., & Xu, T. (2022, January 24). Effect of propofol and sevoflurane on perioperative and postoperative outcomes in lung cancer patients after thoracoscopic surgery. Tropical Journal of Pharmaceutical Research, 20(4), 873-879. https://doi.org/10.4314/tjpr.v20i4.30

    BACKGROUND
  • Wu L, Li Y, Si J. Effects of sevoflurane and propofol on postoperative nausea and vomiting in patients with colorectal cancer placed under general anesthesia: a systematic review and meta-analysis. J Gastrointest Oncol. 2022 Dec;13(6):2963-2972. doi: 10.21037/jgo-22-783.

    PMID: 36636047BACKGROUND
  • Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. doi: 10.1093/oxfordjournals.bja.a013366.

    PMID: 10740540BACKGROUND
  • Miklic Bublic M, Miklic P, Barl P, Matas M, Sekulic A. CROATIAN VERSION OF THE QUALITY OF RECOVERY QUESTIONNAIRE (QoR-40): TRANSCULTURAL ADAPTATION AND VALIDATION. Acta Clin Croat. 2021 Jun;60(2):237-245. doi: 10.20471/acc.2021.60.02.09.

    PMID: 34744273BACKGROUND
  • Kim DH, Min KT, Kim EH, Choi YS, Choi SH. Comparison of the effects of inhalational and total intravenous anesthesia on quality of recovery in patients undergoing endoscopic transsphenoidal pituitary surgery: a randomized controlled trial. Int J Med Sci. 2022 Jun 13;19(6):1056-1064. doi: 10.7150/ijms.72758. eCollection 2022.

    PMID: 35813289BACKGROUND
  • Meng W, Yang C, Wei X, Wang S, Kang F, Huang X, Li J. Type of anesthesia and quality of recovery in male patients undergoing lumbar surgery: a randomized trial comparing propofol-remifentanil total i.v. anesthesia with sevoflurane anesthesia. BMC Anesthesiol. 2021 Dec 1;21(1):300. doi: 10.1186/s12871-021-01519-y.

    PMID: 34852781BACKGROUND
  • Shi CM, Zhou Y, Yang N, Li ZQ, Tao YF, Deng Y, Guo XY. [Quality of psychomotility recovery after propofol sedation for painless gastroscopy and colonoscopy]. Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Apr 18;55(2):324-327. doi: 10.19723/j.issn.1671-167X.2023.02.017. Chinese.

    PMID: 37042144BACKGROUND
  • Kim SH, Ju HM, Choi CH, Park HR, Shin S. Inhalational versus intravenous maintenance of anesthesia for quality of recovery in patients undergoing corrective lower limb osteotomy: A randomized controlled trial. PLoS One. 2021 Feb 19;16(2):e0247089. doi: 10.1371/journal.pone.0247089. eCollection 2021.

    PMID: 33606764BACKGROUND
  • Tomita S, Matsuura N, Ichinohe T. The combined effects of midazolam and propofol sedation on muscle power. Anaesthesia. 2013 May;68(5):478-83. doi: 10.1111/anae.12172. Epub 2013 Mar 22.

    PMID: 23521655BACKGROUND
  • Wen LL, Lin WQ, Zhao WX, Li GC, Bai XH, Xiao JB. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion]. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1):163-5. Chinese.

    PMID: 20118012BACKGROUND
  • Man, Mi, & Han. (2011, September 1). Influence of sevoflurane and propofol on the neuromuscular block effect of cisatracurium. Medical Journal of Chinese People's Liberation Army, 36, 973-975. https://www.semanticscholar.org/paper/Influence-of-sevoflurane-and-propofol-on-the-block-Man-Mi/eb40663a5683c9cc22116520104ca02a66c8b6de#citing-papers

    BACKGROUND
  • Pan, C., Xing, Y., Zhang, D., Liu, X., Zhou, Y., Shi, L., Xu, M., & Zhang, B. (2023, June 6). Combined remifentanil/sevoflurane in paediatric tonsil surgery anesthesia: Effect on recovery time of respiration and consciousness in paediatric patients. Tropical Journal of Pharmaceutical Research, 22(5), 1073-1079. https://doi.org/10.4314/tjpr.v22i5.20

    BACKGROUND
  • Interlandi C, Di Pietro S, Costa GL, Spadola F, Iannelli NM, Macri D, Ferrantelli V, Macri F. Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery. Animals (Basel). 2022 Nov 14;12(22):3134. doi: 10.3390/ani12223134.

    PMID: 36428361BACKGROUND
  • Liu J, Yang L. Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type 2 diabetes mellitus and gastric cancer. Oncol Lett. 2020 Feb;19(2):1187-1194. doi: 10.3892/ol.2019.11201. Epub 2019 Dec 10.

    PMID: 31966048BACKGROUND
  • ALKAYA SOLMAZ, F., & KIRDEMİR, P. (2020, March 2). Enhanced recovery after surgery (ERAS) and anesthesia. Acta Medica Alanya, 4(1), 95-101. https://doi.org/10.30565/medalanya.587027

    BACKGROUND
  • Bennett J, McDonald T, Lieblich S, Piecuch J. Perioperative rehydration in ambulatory anesthesia for dentoalveolar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Sep;88(3):279-84. doi: 10.1016/s1079-2104(99)70028-4.

    PMID: 10503854BACKGROUND
  • Pollard BJ, Bryan A, Bennett D, Faragher EB, Un EN, Keegan M, Wilson A, Burkill M, Beatty PC, Stollery BT, et al. Recovery after oral surgery with halothane, enflurane, isoflurane or propofol anaesthesia. Br J Anaesth. 1994 May;72(5):559-66. doi: 10.1093/bja/72.5.559.

    PMID: 8198909BACKGROUND
  • Asakura A, Mihara T, Goto T. The Effect of Preoperative Oral Carbohydrate or Oral Rehydration Solution on Postoperative Quality of Recovery: A Randomized, Controlled Clinical Trial. PLoS One. 2015 Aug 28;10(8):e0133309. doi: 10.1371/journal.pone.0133309. eCollection 2015.

    PMID: 26317629BACKGROUND
  • Pocock SJ. Clinical Trials: A Practical Approach. Wiley; in 1983

    BACKGROUND
  • Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009 Nov;41(4):1149-60. doi: 10.3758/BRM.41.4.1149.

    PMID: 19897823BACKGROUND

MeSH Terms

Interventions

PropofolSevoflurane

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Ivan Šitum, MD

    UHC Zagreb

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ivan Šitum, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal invesigator

Study Record Dates

First Submitted

February 9, 2024

First Posted

February 23, 2024

Study Start

April 10, 2024

Primary Completion

November 5, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

If there is a need and desire on the part of other researchers, data on patients without personal data can be shared

Locations